SWAG
$1.68
Stran & Company, Inc.
Recent News
Zacks Initiates Coverage of SWAG With Neutral Recommendation
Discover why Zacks, being the first on Wall Street to initiate coverage of the stock, rates Stran as "Neutral". Explore how SWAG is scaling rapidly through acquisitions, improving cost discipline despite ongoing cash flow challenges.
The Zacks Analyst Blog Microsoft, Anheuser-Busch CVS, and Stran & Co
Microsoft leads Zacks' top stock reports as strong cloud share, AI integration and cash flows offset rising competition and heavy AI spending.
Top Stock Reports for Microsoft, Anheuser-Busch & CVS Health
Microsoft's strong cash flows, Azure's 25% cloud share and AI integration drive performance, even as rising debt, capex needs and competition pose risks.
Illustrating Minot Light Capital Partners’ Investment Process: Stran & Company (SWAG) in Focus
Minot Light Capital Partners, an investment management company, released its Q3 2025 investment letter. A copy of the letter can be downloaded here. In the quarter, Minot Light generated solid returns for limited partners, with a net of 7.6%. However, on a net basis, the performance underperformed the benchmarks, particularly the micro-cap benchmark’s 17.1% return. […]
Stran & Co Inc (SWAG) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amid Margin ...
Stran & Co Inc (SWAG) reports a 29% sales increase and improved EBITDA, while navigating challenges from tariffs and acquisition impacts.